Parke Bancorp, Inc. reported a significant net income increase of $7.5 million for Q3 2024, a 16.3% rise over Q2 2024 and an impressive 634.1% surge compared to Q3 2023. The surge was primarily due to the absence of a $9.5 million loss recorded in the previous year’s Q3. Revenue also rose to $33.0 million, […]
MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, has disclosed its financial performance for the third quarter of 2024. The report highlights a net income of $16.7 million, equivalent to $0.65 per diluted share. Although this figure is slightly below the $16.9 million or $0.66 per diluted share recorded in the […]
Home Bancorp, Inc. (Nasdaq: “HBCP”), the parent company of Home Bank, N.A., has reported robust financial results for the third quarter of 2024, with a notable 4% increase in its quarterly dividend. The company announced a net income of $9.4 million or $1.18 per diluted share, an increase from $8.1 million or $1.02 per diluted […]
Virginia National Bankshares Corporation, trading on NASDAQ under the symbol VABK, has reported its earnings for the third quarter of 2024. The company’s net income stood at $4.6 million, translating to $0.85 per diluted share. This marks a slight dip from the $4.7 million, or $0.86 per diluted share, posted in Q3 of 2023. Over […]
Samfine Creation Holdings Group Limited made a sensational debut on the Nasdaq, with its shares skyrocketing by 37% on the first day of trading. The Hong Kong-based printing services provider, which listed under the ticker symbol SFHG, saw its stock price shoot up to $5.49 per share, well above the initial offering range of $4 […]
In a sensational opening on Wall Street, Ceribell’s stock surged by 36% in its trading debut, reflecting immense investor enthusiasm for the neurotech company’s AI-powered seizure detection technology. Ceribell priced its initial public offering (IPO) at $17 per share, the top of its proposed range, and quickly saw its valuation skyrocket as shares began trading […]
AGBA Group Holding Limited (NASDAQ: AGBA) saw a significant 28% rise in its stock price, riding on the anticipation of its upcoming merger with Triller Corp. The merger, valued at $4 billion, is expected to close on or around October 14, 2024, pending final approval from Nasdaq. This strategic move aims to combine AGBA’s multi-channel […]
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company focused on cancer immunotherapies, has seen its shares decline significantly after announcing a $150 million public offering. The announcement came as a surprise to investors, with the stock experiencing a sharp drop of approximately 10%, closing at $9.95 from its previous levels above $11. This downturn has […]
Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical company, listed on the ASX (IMC) and NASDAQ (IMRN), focuses on developing oral immunotherapies for gut-mediated diseases, including its flagship product, Travelan. Recently, NMRC concluded an interim analysis of a […]
Banzai International experienced a dramatic 96% surge in its stock value, hitting $8.23 after announcing a substantial debt restructuring plan worth $24.8 million. This comes after the Seattle-based marketing technology company made a decisive move to tackle its financial burdens by restructuring its debt and extending its cash runway. The company’s shares had been down […]